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Professor John M. Tarbell’s contributions to the
biomedical engineering community have been substantial through service, education, and research.
These contributions have spanned approximately 45
years with his research eﬀorts impactful in areas of
mechanical heart valves, artiﬁcial hearts, cardiovascular ﬂuid mechanics, vascular permeability, and
mechanobiology. Professor Tarbell’s legacy goes well
beyond just his own research eﬀorts, and this special
issue of Cardiovascular Engineering and Technology
celebrates his impact through collaborators, trainees,
and close colleagues. To celebrate the lifetime
achievement of Professor Tarbell, his former trainees,
collaborators and colleagues have contributed ten papers including two review papers on the areas of artiﬁcial heart, heart valves, glycocalyx, and endothelial
permeability to macromolecules and therapeutics in
this Special Issue of Cardiovascular Engineering and
Technology. Here, we ﬁrst introduce each paper and
Professor Tarbell reﬂects on his professional success,
which continues today.
The papers collected in this Special Edition are
grouped into the areas of (1) mechanical heart valve,
artiﬁcial hearts, and heart valves, (2) the glycocalyx, (3)
endothelial permeability, and (4) endothelial gene and
drug delivery.
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MANNING ET AL.25 JOHN M. TARBELL:
ARTIFICIAL HEART AND MECHANICAL
HEART VALVE RESEARCH CONTRIBUTIONS
Keefe Manning, Professor at the Pennsylvania
State University (Penn State), was a former postdoctoral fellow in John Tarbell’s lab at Penn State. In
this Special Issue, he and his colleagues including
Gerson Rosenberg, Tarbell’s former student at Penn
State, review Professor Tarbell’s contributions to the
artiﬁcial heart and mechanical heart valve research at
Penn State.25 John Tarbell initially developed techniques to measure shear stress using hot-ﬁlm
anemometry. In collaboration with colleagues at Penn
State Hershey Medical Center, John studied ﬂuid
mechanics of artiﬁcial heart and ventricular assist
devices, which have provided crucial guidance for the
pump development.
HOWSMAN AND SACKS.17 ON VALVE
INTERSTITIAL CELL SIGNALING: THE LINK
BETWEEN MULTISCALE MECHANICS
AND MECHANOBIOLOGY
Michael Sacks, Professor at the University of Texas
Austin, is a long-time colleague of John Tarbell in the
ﬁeld of heart valve mechanics. In this Special Issue,
Sacks and Daniel P. Howsmon provide an in-depth
review on the current understanding in vascular
mechanobiology.17 In an attempt to provide a better
understanding by which heart valves function under
the mechanically demanding environment, they propose mechanistic mathematical modeling between the
mechanoresponses of vascular interstitial cells. This
should be helpful in identiﬁcation of drug targets for
treating valve disease.
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SALIM ET AL.30 TRANSCATHETER AORTIC
VALVE THROMBOGENESIS: A FOREIGN
MATERIALS PERSPECTIVE
Ajit P. Yoganathan, Professor at Georgia Institute
of Technology, is a long-standing close colleague of
John Tarbell in the ﬁeld of ﬂuid mechanics of heart
valves. In this Special Issue, Yoganathan and colleagues report their work on the thrombogenic
potential of transcatheter aortic valves (TAV).30 Aortic
stenosis is primarily caused by aortic valve ﬁbrosis and
calciﬁcation. Since there are no drugs available to treat
aortic stenosis, aortic valve replacement through either
a surgical or transcatheter approach are the only options currently. Increasingly, minimally invasive transcatheter aortic valve replacement (TAVR) is used to
treat aortic stenosis. Leaﬂet thrombosis is a major
clinical complication associated with TAVR. However,
despite its clinical importance, the mechanism by
which thrombus formation in TAVs is not well
understood. In this report, the Yoganathan team
studies a mechanism using human blood and the SAPIEN XT valve. They show a lower thrombogenic
potential of intact SAPIEN XT valves compared to the
stent-with-skirt (leaﬂets removed from a SAPIEN XT
valve), indicating the signiﬁcance of blood–stent and
blood–skirt interactions in TAV thrombosis.
WEINBAUM ET AL.37 THE GLYCOCALYX
AND ITS ROLE IN VASCULAR PHYSIOLOGY
AND VASCULAR RELATED DISEASES
Professors Sheldon Weinbaum and Bingmei M. Fu
are close colleagues at the City College of New York
(CUNY), while Limary M Cancel is a former PhD
student and current colleague of John Tarbell. In this
Special Issue, Weinbaum, Cancel, and Fu joined with
John Tarbell to review their common topic of interests
on the glycocalyx.37 They summarize the current
knowledge on the role of endothelial glycocalyx in
intercellular interactions and how it is implicated in
atherosclerosis and cancer metastasis. The luminal
surface of vascular endothelial cells are coated with
glycocalyx, which is the hydrated gel-like structure.
Glycocalyx is comprised of core membrane proteins
syndecans, and glypicans, with their covalently bound
glycosaminoglycans (heparin sulfate, chondroitin sulfate, and hyaluronic acid). In Part A of this paper, the
authors provide a state-of-the art review on the function of glycocalyx in basic vascular physiology and
vascular-related diseases. The paper discusses the Michel-Weinbaum glycocalyx model and its physiological
ramiﬁcations. New insights into the role of glycocalyx
in shear stress-induced release of nitric oxide is disBIOMEDICAL
ENGINEERING
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cussed. Major technical advances in structure and
function of glycocalyx are also discussed. In part (B),
they summarize the role of glycocalyx in cardiovascular diseases, aging, cancer, and infectious disease
including Corona viruses and further discuss the
potential drugs and therapeutic strategies to target
glycocalyx and associated diseases.
MENSAH ET AL.26 ENDOTHELIAL
GLYCOCALYX-MEDIATED INTERCELLULAR
INTERACTIONS: MECHANISMS
AND IMPLICATIONS FOR ATHEROSCLEROSIS
AND CANCER METASTASIS
Eno Ebong, Associate Professor at Northeastern
University, was trained with John Tarbell as his postdoctoral fellow at CUNY. In this Special Issue, Ebong
and her colleagues review the role of glycocalyx in
atherosclerosis and cancer.26 Degradation of the glycocalyx disrupts endothelial cell function and is
implicated in the onset of diseases such as atherosclerosis and cancer. The paper discusses how glycocalyx
regulates endothelial function by regulating intercellular interactions between endothelial cells with their
neighboring endothelial cells and cancer cells. The role
of a junctional protein such as Connexin 43 in
interendothelial communication and the cell surface
receptor E-selectin in endothelial-tumor cell interactions is discussed, and the potential of glycocalyx
protection and regeneration as therapeutic strategies is
also discussed.
DU ET AL.10 ANISODAMINE HYDROBROMIDE
PROTECTS GLYCOCALYX AND AGAINST
THE LIPOPOLYSACCHARIDE-INDUCED
INCREASES IN MICROVASCULAR
ENDOTHELIAL LAYER PERMEABILITY
AND NITRIC OXIDE PRODUCTION
Ye Zeng, Associate Professor at Sichuan University,
received postdoctoral training in the Tarbell Lab at
CUNY. In this Special Issue, Zeng and his team
studies the role of an Anisodamine hydrobromide (Ani
HBr) in protection of endothelial glycocalyx layer,
which in turn preserves the barrier function and nitric
oxide production.10 Ani HBr is an active component of
Scoopolia tangutica maxim and is used to improve
microcirculation in patients with cardiovascular disease and sepsis, but its mechanism is still not well
understood. Here, Zeng’s team shows that treatment
with ani HBr protects glycocalyx layer of a human
cerebral microvascular endothelial line (hCMEC/D3)
in response to the bacterial endotoxin lipopolysac-
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charide. Ani HBr also protected endothelial permeability barrier and junctional integrity against the
lipopolysaccharide challenge. This ﬁnding suggests a
potential use of Ani HBr as a drug to protect the
endothelial glycocalyx and associated diseases.
DULL ET AL.11 THE GLYCOCALYX
AND PRESSURE-DEPENDENT
TRANSCELLULAR ALBUMIN TRANSPORT
Randy Dull, Professor of Anesthesiology at
University of Arizona, received his Ph.D. under the comentorship of Professors John Tarbell and Ted Hollis
at Penn State, before he received his M.D. In this
Special Issue, Dull and colleague’s studies examine the
role of glycocalyx, nitric oxide, and reactive oxygen
species on endothelial permeability to albumin in
response to pressure.11 Hydrostatic pressure is known
to activate endothelial signaling pathways that modulate barrier function and vascular permeability. His
team used rat lung microvascular endothelial cells to
measure uptake and transcellular uptake of albumin in
response to hydrostatic pressure. Using heparanase to
disrupt glycocalyx, L-NAME to inhibit endothelial
nitric oxide synthase (eNOS), and apocynin to chelate
reactive oxygen species, his team demonstrates that
heparan sulfate, a key component of glycocalyx,
eNOS, and reactive oxygen species play important
regulatory roles in uptake and transcellular transport
of macromolecules across endothelial cells in response
to pressure conditions. The physiological and clinical
implications of this ﬁnding is discussed.
16

GHIM ET AL. THE ROLE OF TRICELLULAR
JUNCTIONS IN THE TRANSPORT
OF MACROMOLECULES ACROSS
ENDOTHELIUM
Peter Weinberg, Professor at the Imperial College
London, is John’s long-time colleague since they began
collaborating at Imperial College during his sabbatical
in the Colin Caro’s Lab. In this Special Issue, Weinberg and colleagues review the transport of macromolecules across vascular endothelial cells with special
emphasis on paracellular junctions.16 Macromolecules
such as those with the sizes of albumin and low density
lipoproteins use either transcellular or paracellular
routes to pass through vascular endothelial cells, but
the detailed understanding on their relative importance
of each route is unclear. In this study, the authors
studied the role of endothelial tricellular junctions in
paracellular permeability using human aortic
endothelial cells, ﬂuorescent Avidin binding to

biotinylated gelatin matrix, and machine-learning aided image analyses. They also investigated the role of
agonists (sphingosine-1-phoshate and thrombin) and
shear stress on the tricellular pathway. Their results
show the dominance of the tricellular junctions for the
macromolecule transport in response to the agonists
and shear stress.
ZHANG ET AL.41 TRANSCELLULAR MODEL
FOR NEUTRAL AND CHARGED
NANOPARTICLES ACROSS AN IN VITRO
BLOOD–BRAIN BARRIER
Bingmei M. Fu, Associate Professor at CUNY, is a
close collaborator of Professor Tarbell. Blood–brain
barrier (BBB) is critical in limiting the transfer of most
blood borne molecules including toxins across the
endothelium to the brain tissue. On the other hand,
BBB is a signiﬁcant hindrance in delivering drugs to
treat brain disease. In this Special Issue,41 Bingmei Fu
and her colleagues investigated transcellular characteristics of various nanoparticles across brain
endothelial cells to develop optimal drug delivery
vehicles. Using the mouse brain microvascular
endothelial cells (bEnd3 cells), they found that positively charged nanoparticles (20–100 nm diameter)
show favorable transcellular permeability, due in part
to the negative charge of the surface glycocalyx of the
BBB. Their predictive model for nanoparticle size and
charge should be helpful in developing optimal drug
delivery strategy across BBB.
DOSTA ET AL.9 DELIVERY OF SIRNA
TO ENDOTHELIAL CELLS IN VITRO USING
LYS/HIS OLIGOPEPTIDE-MODIFIED
POLY(B-AMINO ESTER) NANOPARTICLE
Hanjoong Jo, Professor at Emory University and
Georgia Tech, was co-mentored by Professors John
Tarbell and Ted Hollis at Penn State. In this Special
Issue, Jo and his colleagues report on poly(b-amino
ester)s (pBAEs) nanoparticles that were used to deliver
siRNAs (small inhibitory RNAs) to vascular
endothelial cells in vitro and in vivo.9 Endothelial cell
dysfunction plays a critical role in atherosclerotic and
pulmonary diseases and cancer. Here, the authors
developed the lysine-/histidine-oligopeptide modiﬁed
pBAE (C6-KH) nanoparticle carrying siRNAs, which
was able to speciﬁcally knockdown ICAM2 in
endothelial cells both in cultured mouse aortic
endothelial cells in vitro and mouse artery in vivo. In
addition, they found that C6-KH pBAEs nanoparticles
can be used for tissue-selective delivery of siRNAs to
BIOMEDICAL
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the aorta and lung, while avoiding the liver and heart.
The tissue-selectivity may be used for targeted drug
and gene therapies.
We hope you enjoy and appreciate Prof. Tarbell’s
reﬂection and his many contributions through this
special issue. Personally, he is an amazing mentor and
friend that has help shape our careers.
Sincerely,
Hanjoong Jo and Keefe Manning

FOREWORD
This special issue of CVET recognizing my career
contributions to cardiovascular research has been
organized by my good friends Ajit Yoganathan,
Hanjoong Jo, and Keefe Manning. They asked me to
write a brief introduction reﬂecting on my career, and I
have decided to constrain my comments to research,
not discussing teaching and administration, which
were so important to me as well. I have included enough depth to allow me to recognize many important
people who inﬂuenced me, but I have avoided an
exhaustive review of my publications. I hope you enjoy
the excellent papers in this special issue of CVET.

REFLECTIONS ON A RESEARCH CAREER:
JOHN TARBELL
Like many of my generation who have had careers
in Biomedical Engineering, my original training was
not in BME. I obtained BS (Rutgers University), MS
and PhD (University of Delaware) degrees in Chemical
Engineering. I received strong training in ﬂuid
mechanics at Delaware and the ﬁrst research that
ultimately proved relevant to my career was my Masters thesis work ‘‘A Numerical Study of Fluid Flow
and Heat Transfer in Helical Coils’’. That may not
sound terribly relevant at ﬁrst, but it introduced me to
the complexity of ﬂow that could be induced by the
curved tube (artery) geometry, including secondary
ﬂows (Dean vortices) and the skewing of the axial
velocity proﬁle toward the outer wall where shear
stresses at the wall are higher than at the inner wall.
This ultimately turned out to be relevant to the role of
ﬂuid mechanics in atherosclerosis that is localized in
the low shear stress regions of inner curvatures in
blood vessels.
When I was recruited by Penn State University’s
Chemical Engineering Department as an Assistant
Professor in 1976 my initial research projects were not
related to biomedical engineering at all. My ﬁrst 13
publications were non-biological and dealt with such
topics as air pollution kinetics and the stability of
BIOMEDICAL
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chemical reactors.31,27 My last non-biological publication actually appeared in 1993.19 Fortunately during
my early years at Penn State I received strong
encouragement from my chemical engineering colleague, Jim Ultman who worked in the area of respiratory transport, to pursue my bioengineering
interests. In those early years I knew that I had a
passion for research and was eager to work on any
interesting problem be it a chemical reactor or ﬂow in
the aorta.
My earliest attraction to biomedical engineering
research was inspired by the classic paper by Colin
Caro et al.6 which I had encountered in my ﬂuid
mechanics studies as a graduate student. This paper
put forth the ‘‘low shear stress theory of atherogenesis’’
based on observations of atherosclerotic plaque
localization in animals and humans. It was at odds
with the popular ‘‘high shear stress theory’’ introduced
by Donald Fry.15 The Caro et al. paper also contained
an appendix with a mathematical model of mass
transport to and from the artery wall. 6 My eyes were
opened to the possibility that chemical engineering
principles of ﬂuid mechanics and mass transfer could
be applied to elucidate a signiﬁcant biomedical problem—atherosclerosis. I soon found out that there was a
faculty member in the Physiology Dept. at Penn State
(Ted Hollis) who was studying the effects of ﬂuid shear
stress on endothelial cells.8 I began a collaboration
with Ted that led to my ﬁrst biomedical engineering
publication32 (‘‘A Note on Wall Shear Stress in the
Aorta’’).
My interest in atherogenesis continued to grow
mainly from the ﬂuid mechanics perspective. But I
knew that I needed to understand cellular behavior,
and I was very fortunate to be invited for my ﬁrst
sabbatical to the ‘‘Physiological Flow Studies Unit’’
(PFSU) at Imperial College, London directed by Colin
Caro. Working closely with the late John Lever and
Colin on ex-vivo experiments in rabbit carotid arteries
we measured hydraulic conductivity in response to
changes in albumin concentration34 and shear stress.22
These studies demonstrated shear dependent hydraulic
conductivity of the artery wall and initiated my
enduring interest in shear dependent transport properties of arteries. While at the PFSU I met a bright
young PhD student in the lab, Peter Weinberg, a
contributor to this volume, who has sustained a career
studying arterial wall transport and the inﬂuence of
ﬂuid mechanics. Peter has been a valued colleague and
one who has consistently challenged conventional
wisdom in his ﬁeld.
When I returned from London, I knew I wanted to
study shear eﬀects on endothelial transport, but it was
clear to me that I could not pursue the animal experiments we had performed in London—they were just
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too technically diﬃcult. I thought cell culture experiments might be more accessible to an engineer. I was
fortunate to co-mentor two physiology PhD students
with Ted Hollis (Hanjoong Jo and Randy Dull) to
initiate studies of shear dependent transport across
endothelial cell monolayers in vitro. With Hanjoong,
currently at Emory University School of Medicine and
Georgia Tech BME and a Co-Editor of this special
issue, we developed a parallel plate ﬂow chamber with
a permeable wall section and demonstrated shear
dependent albumin permeability.18 With Randy, currently at the University of Arizona School of Medicine
and also a contributor, we were able to measure hydraulic conductivity in vitro and to demonstrate the
existence of a ‘‘large pore’’ pathway for albumin consistent with in vivo studies.12 Over subsequent years an
additional 35 papers on endothelial transport have
been published.
In parallel to my burgeoning interest in ﬂuid
mechanics and atherogenesis, I became aware that
there was an artiﬁcial heart program on our campus at
University Park. It was established in collaboration
with the Penn State Medical School at Hershey where
the program was founded by William S. Pierce (MD)
in the early 1960s. An engineering arm of the team was
established at University Park in the early 1970s under
the direction of mechanical engineering professors
John Brighton and Win Phillips. As I was renting Win
Phillips’ house during my ﬁrst year at Penn State while
he was on sabbatical, my interest in the program was
peaked. A few years later both Win Phillips and John
Brighton left Penn State and I joined the group along
with the late David Geselowitz from electrical engineering.
I began to direct the ﬂuid mechanics aspects of the
program in the early 1980s. With the help of Kirk
Shung, an ultrasound expert in BME, and Steve
Deutsch, a laser-Doppler velocimetry and particle
image velocimetry expert in the Naval Fluid Mechanics Lab at Penn State, we assembled the tools and
expertise to begin examining ﬂow ﬁelds within artiﬁcial
heart ventricles.33,1 This led to my association with Ajit
Yoganathan, founding editor of CVET and a contributor to this special issue. Ajit has been a valued
colleague and friend throughout my career. Under
Ajit’s inﬂuence my lab began to investigate the ﬂuid
mechanics of mechanical heart valves in artiﬁcial
hearts. We studied turbulence in forward ﬂow and
regurgitant ﬂow2 and made our most original contributions in the area of cavitation that occurs when
mechanical valve leaﬂets rebound from their occluders
at closure.21,39 Cavitation can cause valve material
damage and blood damage and generate nuclei for
dissolved gas bubble growth that may lead to emboli in
the brain.4 Ultimately we began to look at blood

damage generated within the artiﬁcial heart and by
ﬂow through the valves. This marked the ﬁrst introduction of biological measurements to the artiﬁcial
heart lab and this was aided by John Frangos, who was
a young colleague in Chemical Engineering at Penn
State.20 At the end of 2002 I left Penn State for a new
position at The City College of New York and that
brought my artiﬁcial heart research career to an end.
Fortunately I had an outstanding post doc in the lab
for my last 5 years at Penn State–Keefe Manning,24
who is a co-Editor of this special issue. Keefe soon
became an Assistant Professor of BME at Penn State
and took over direction of the Artiﬁcial Heart Lab
which he oversees to this day.
In 1998 I took my second sabbatical in Boston with
Rakesh Jain at the Steele Laboratory aﬃliated with
Massachusetts General Hospital at Harvard University. Rakesh and I were classmates at Delaware in
Chemical Engineering and he had established a strong
research program in cancer research and the tumor
microenvironment. Using equipment I transported
from my laboratory at Penn State, I studied the eﬀect
of VEGF on the permeability of endothelial monolayers, working closely with Lance Munn who continues to be my collaborator today.7 During my stay, I
became aware of the strong interstitial ﬂow present in
the microenvironment of solid tumors that is associated with leaky blood vessels induced by VEGF. Using
theory we published in 1995 for interstitial ﬂow in
arteries,36 we estimated signiﬁcant ﬂuid shear stress on
cancer cells in tumors induced by interstitial ﬂow. This
led to a series of studies of the effect of interstitial ﬂow
on tumor cells suspended in 3-dimensional collagen
gels. We observed that migration of highly metastatic
cancer cell lines was enhanced by interstitial ﬂow
whereas non-metastatic cells were not affected by
interstitial ﬂow.28 This led to the hypothesis that
interstitial ﬂow enhances metastasis, and in collaboration with Lance Munn, this was demonstrated in
animal studies in 2016.29
Shelly Weinbaum, whom I had known for many
years through our common interest in arterial wall
transport, recruited me to join the new BME Department at City College as the Coulter Professor and
Department Chair in 2003. My PhD student, Limary
Cancel, a contributor to this issue, along with Jeﬀ
Garanich and Mike Dancu helped set up the new lab.
Limary stayed with me after her PhD, became a post
doc, and is now a research associate and critical partner in my lab. Soon after arriving at City College, I
discovered that Shelly and I were both studying the
endothelial surface glycocalyx layer—a glycan rich gel
like structure coating cell surfaces. I had shown in 2003
that the glycocalyx was a mechanosensor and transducer responsible for ﬂow dependent induction of niBIOMEDICAL
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tric oxide production that, among many other functions, is responsible for ﬂow mediated vasodilation.14
Shelly had shown that the glycocalyx was responsible
for shear dependent remodeling of endothelial cells.35
In 2007, Shelly and I along with Ed Damiano at
Boston University published a highly cited review paper on the glycocalyx.38 In this current issue, we
teamed up with Limary Cancel and my City College
BME colleague, Bingmei Fu, to present a new and
exhaustive review of the glycocalyx.37
Most of my recent eﬀort at City College has been
focused on the glycocalyx. Two of my latest and most
productive post docs who studied the glycocalyx while
at City have moved on to academic positions and
continue studying the glycocalyx. Eno Ebong, Associate Professor at Northeastern University and Ye
Zeng, Associate Professor at Sichuan University have
each contributed glycocalyx papers to this special issue. At City College, in collaboration with David
Spray at Albert Einstein School of Medicine, Eno
produced the ﬁrst cryo-EM images of the glycocalyx
that overcame the dehydration artifacts associated
with conventional EM and showed the full extent of
the layer.13 In collaboration with Victor Rizzo at
Temple University School of Medicine, Ye observed
the motility of glypican 1, an important membrane
bound heparan sulfate proteoglycan (HSPG) in the
glycocalyx, as it moved on lipid rafts in response to
ﬂuid shear stress while the transmembrane HSPG
syndecan 1 was stationary in the presence of shear
stress.40 More recently, along with PhD student Anne
Marie Bartosch, we showed that glypican 1 is the upstream mechanosensor for shear-induced NO production that acts through the intermediary junction
protein, PECAM 1.3 And most recently, with post doc
Marwa Mahmoud, we showed that endothelial substrate stiffness that is associated with hypertension and
aging, leads to glycocalyx suppression and endothelial
dysfunction being mediated by a loss of glypican 1.23
At the time of this writing my lab continues to work
on substrate stiﬀness eﬀects mediated by the glycocalyx
with Marwa Mahmoud, methods to suppress cancer
metastasis through glycocalyx modiﬁcation with Limary Cancel, Heriberto Moran and Lance Munn, and
transport properties of the blood–brain barrier associated with transcranial direct current stimulation in
collaboration with Limary Cancel, Bingmei Fu and my
neural engineering colleague, Marom Bikson.5
As I look back on my career, which I am pleased to
say is not yet over, I realize that I have worked on
many problems, some would say too many. Actually I
gave up on several areas that interested me to try and
provide more focus and depth to my endeavors. But in
the end I couldn’t resist the excitement of discovery
that was aﬀorded by the many areas of research I have
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continued to pursue. As the saying goes, ‘‘I did it my
way’’, and I have no regrets.
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